Literature DB >> 7340886

The effect of chronic propranolol treatment on overnight plasma levels of anterior pituitary and related hormones.

A M Dart, M J Lewis, G V Groom, E M Meek, A H Henderson.   

Abstract

1 Treatment of eight healthy males with propranolol (80 mg twice daily) for 6 weeks resulted in a significant reduction in overnight plasma levels of prolactin and LH. 2 Plasma testosterone levels were elevated whilst GH and cortisol were unchanged by such treatment. 3 Measurement of overnight hormone levels 48 h after discontinuing treatment showed no evidence of a 'rebound' phenomenon. 4 Cortisol, GH, prolactin, and testosterone plasma levels all showed time dependent changes: propranolol treatment significantly altered the time course of cortisol but not of the other hormones. 5 The effects of chronic propranolol treatment are discussed in terms of a probable direct central action of the drug. In addition the lowered plasma prolactin levels may directly contribute to the hypotensive action of propranolol.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7340886      PMCID: PMC1401931          DOI: 10.1111/j.1365-2125.1981.tb01319.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Brain neurotransmitters, amygdala, and control of gonadotropin and prolactin secretion.

Authors:  J Borrell; F Piva; M Motta; S Leto; L Martini
Journal:  Adv Biochem Psychopharmacol       Date:  1977

Review 2.  The clinical pharmacology of beta-adrenoceptor-blocking drugs.

Authors:  M E Conolly; F Kersting; C T Dollery
Journal:  Prog Cardiovasc Dis       Date:  1976 Nov-Dec       Impact factor: 8.194

3.  Reduction in sympathetic nervous activity as a mechanism for hypotensive effect of propranolol.

Authors:  P J Lewis; G Haeusler
Journal:  Nature       Date:  1975-07-31       Impact factor: 49.962

4.  Nocturnal increase of plasma testosterone in men: relation to gonadotropins and prolactin.

Authors:  R T Rubin; P R Gouin; A Lubin; R E Poland; K M Pirke
Journal:  J Clin Endocrinol Metab       Date:  1975-06       Impact factor: 5.958

Review 5.  The measurement of human gonadotrophins by radioimmunoassay.

Authors:  G V Groom
Journal:  J Reprod Fertil       Date:  1977-09

6.  Actions of prolactin on human renal function.

Authors:  D F Horrobin; I J Lloyd; A Lipton; P G Burstyn; N Durkin; K L Muiruri
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

7.  Sleep-related, nychthermeral and briefly episodic variation in human plasma prolactin concentrations.

Authors:  D C Parker; L G Rossman; E F Vander Laan
Journal:  J Clin Endocrinol Metab       Date:  1973-06       Impact factor: 5.958

8.  Effect of intravenous prolactin infusion on arterial blood pressure in rabbits.

Authors:  D F Horrobin; M S Manku; P G Burstyn
Journal:  Cardiovasc Res       Date:  1973-09       Impact factor: 10.787

9.  Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.

Authors:  L Hansson; H Aberg; S Jameson; B Karlberg; R Malmcrona
Journal:  Acta Med Scand       Date:  1973-12

10.  The effects of propranolol and acebutolol on the overnight plasma levels of anterior pituitary and related hormones.

Authors:  M J Lewis; G V Groom; R Barber; A H Henderson
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

View more
  6 in total

1.  Beta-blocker effects on sexual function in normal males.

Authors:  R C Rosen; J B Kostis; A W Jekelis
Journal:  Arch Sex Behav       Date:  1988-06

2.  The effect of propranolol on luteinising hormone and prolactin plasma concentrations in hypertensive women.

Authors:  A M Dart; K McHardy; H E Barber
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

3.  β-Adrenoceptor Blockade Moderates Neuroinflammation in Male and Female EAE Rats and Abrogates Sexual Dimorphisms in the Major Neuroinflammatory Pathways by Being More Efficient in Males.

Authors:  Ivan Pilipović; Zorica Stojić-Vukanić; Ivana Prijić; Nebojša Jasnić; Jelena Djordjević; Gordana Leposavić
Journal:  Cell Mol Neurobiol       Date:  2022-07-08       Impact factor: 5.046

4.  Changes in blood chemistry in hypertensive patients during propranolol therapy.

Authors:  F Andreasen; P Jakobsen; H J Kornerup; E B Pedersen; O L Pedersen; J Weeke
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

5.  Withdrawal phenomena after atenolol and bopindolol: hormonal changes in normal volunteers.

Authors:  R J Walden; B Tomlinson; B Graham; C Smith; D J Betteridge; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

6.  The effect of propranolol on CSF amine metabolites in psychiatric patients.

Authors:  D J King; S J Cooper; J Liddle
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.